CAT No: CP26608
CAS No:197632-75-0
Synonyms/Alias:197632-75-0;FMOC-N-ME-TRP(BOC)-OH;Fmoc-metrp(boc)-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid;L-Tryptophan, 1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]propanoic acid;Na-(((9H-fluoren-9-yl)methoxy)carbonyl)-1-(tert-butoxycarbonyl)-Na-methyl-L-tryptophan;1-Boc-N-Fmoc-N-methyl-L-tryptophan;(2S)-3-[1-(TERT-BUTOXYCARBONYL)INDOL-3-YL]-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL](METHYL)AMINO}PROPANOIC ACID;MFCD02094403;SCHEMBL21404762;AKOS015909079;N"-Fmoc-N'-Me-N-Boc--L-tryptophan;CS-W007056;BP-21135;DS-15063;S-197632-75-0;1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-yLmethoxy)carbonyl]-N-methyl-L-tryptophan;870-680-9;L-Tryptophan,1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.